DRAXIMAGE MDP: Affected lot may contain particulate matter
Last updated
Summary
Product
DRAXIMAGE MDP
Issue
Health products - Product quality
What to do
See instructions below.
Audience
Healthcare
Hospitals
Industry
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
DRAXIMAGE MDP |
DRAXIMAGE MDP |
DIN 02329409 |
Powder For Solution |
MEDRONIC ACID 10 MG / VIAL |
1K144 |
Issue
Affected lot may contain particulate matter
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesale, Healthcare Establishments
Details
Original published date: 2022-08-30
Alert / recall type
Health product recall
Category
Health product - Drugs - Radiopharmaceuticals
Companies
JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
16751 Trans Canada Hwy
Kirkland
Quebec
Canada H9H 4J4
Published by
Health Canada
Audience
Healthcare
Hospitals
Industry
Recall class
Type I
Identification number
RA-64521